Non-24 hour sleep-wake cycle

Name	Development Level	Target Family

Name	Description
tasimelteon	an agonist at melatonin MT1 and MT2 receptors, these receptors are thought to be involved in the control of circadian rhythms

TCRDv4.6.9
DrugCentral Indication
DrugCentral
tasimelteon